{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:06:09Z","timestamp":1783595169713,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.clinthera.2012.03.008","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T16:19:49Z","timestamp":1334247589000},"page":"1112-1120","source":"Crossref","is-referenced-by-count":22,"title":["Tacrolimus Versus Intravenous Pulse Cyclophosphamide Therapy in Chinese Adults With Steroid-Resistant Idiopathic Minimal Change Nephropathy: A Multicenter, Open-Label, Nonrandomized Cohort Trial"],"prefix":"10.1016","volume":"34","author":[{"given":"Heng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangbiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2012.03.008_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: clinical characteristics, treatment and outcomes","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clinthera.2012.03.008_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000046215","article-title":"Adult-onset minimal change disease among Taiwanese: clinical features, therapeutic response, and prognosis","volume":"21","author":"Huang","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.clinthera.2012.03.008_bib3","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1046\/j.1523-1755.1999.00408.x","article-title":"Changing patterns in the histopathology of idiopathic nephrotic syndrome in children","volume":"55","author":"Bonilla-Felix","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2012.03.008_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00467-003-1095-3","article-title":"Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome","volume":"18","author":"Baipai","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clinthera.2012.03.008_bib5","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00467-008-0794-1","article-title":"Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome\u2014a randomized controlled multicentre trial by the Arbeitsgemeinschaft fur Padiatrische Nephrologie","volume":"23","author":"Plank","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clinthera.2012.03.008_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0272-6386(12)80654-8","article-title":"Long-term cyclosporine A treatment of steroid-resistant and steroid-dependant nephrotic syndrome","volume":"18","author":"Melcoton","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2012.03.008_bib7","first-page":"316","article-title":"Comparison of the effects of FK-506, cyclosporin A and rapamycin on IL-2 production","volume":"73","author":"Henderson","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.clinthera.2012.03.008_bib8","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00007890-199403270-00016","article-title":"FK-506 \u201crescue\u201d for resistant rejection of renal allografts under primary cyclosporine immunosuppression","volume":"57","author":"Jordan","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2012.03.008_bib9","first-page":"1286","article-title":"Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome","volume":"8","author":"McCauley","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2012.03.008_bib10","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/ndt\/12.11.2433","article-title":"Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome","volume":"12","author":"Schweda","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2012.03.008_bib11","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/ndt\/gfm688","article-title":"Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children","volume":"23","author":"Gulati","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2012.03.008_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5414\/CNP65393","article-title":"Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome","volume":"65","author":"Westhoff","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2012.03.008_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00467-003-1370-3","article-title":"Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome","volume":"19","author":"Loeffler","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clinthera.2012.03.008_bib14","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/ndt\/gfm637","article-title":"Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome","volume":"23","author":"Li","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2012.03.008_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2009.02.018","article-title":"Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR","volume":"54","author":"Li","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2012.03.008_bib16","first-page":"584","article-title":"Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria","volume":"21","author":"Li","year":"2008","journal-title":"J Nephrol"},{"key":"10.1016\/j.clinthera.2012.03.008_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00868243","article-title":"Intravenous pulse cyclophosphamide\u2014a new regime for steroid-resistant minimal change nephrotic syndrome","volume":"8","author":"Elhence","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clinthera.2012.03.008_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00467-003-1095-3","article-title":"Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome","volume":"18","author":"Bajpai","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clinthera.2012.03.008_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2012.03.008_bib20","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/ndt\/gfi274","article-title":"Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus","volume":"21","author":"Sinha","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2012.03.008_bib21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.ki.5002215","article-title":"Tacrolimus monotherapy in membranous nephropathy: A randomized controlled trial","volume":"71","author":"Praga","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2012.03.008_bib22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2006.05.015","article-title":"Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial","volume":"45","author":"Orlent","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2012.03.008_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5414\/CNP65393","article-title":"Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome","volume":"65","author":"Westhoff","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2012.03.008_bib24","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1016\/j.ajkd.2003.07.011","article-title":"Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome","volume":"42","author":"Tang","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2012.03.008_bib25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1159\/000065276","article-title":"Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil","volume":"22","author":"Mogyorosi","year":"2002","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.clinthera.2012.03.008_bib26","first-page":"375","article-title":"The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea","volume":"43","author":"Lee","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2012.03.008_bib27","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/ki.1993.194","article-title":"A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome","volume":"43","author":"Ponticelli","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2012.03.008_bib28","first-page":"84","article-title":"Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up","volume":"43","author":"Tune","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2012.03.008_bib29","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0022-3476(05)82020-7","article-title":"Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone","volume":"125","author":"Niaudet","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinthera.2012.03.008_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000186990","article-title":"Inhibition of vascular permeability factor production by ciclosporin in minimal change nephrotic syndrome","volume":"62","author":"Maruyama","year":"1992","journal-title":"Nephron"},{"key":"10.1016\/j.clinthera.2012.03.008_bib31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1159\/000187876","article-title":"FK 506 for vascular permeability factor production in minimal change nephrotic syndrome","volume":"66","author":"Maruyama","year":"1994","journal-title":"Nephron"},{"key":"10.1016\/j.clinthera.2012.03.008_bib32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/ndt\/17.4.655","article-title":"Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up","volume":"17","author":"Segarra","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2012.03.008_bib33","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/ndt\/gfh536","article-title":"Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy","volume":"19","author":"Duncan","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2012.03.008_bib34","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1093\/ndt\/gfm366","article-title":"Treatment of idiopathic membranous nephropathy with the combination of steroids, tacrolimus and mycophenolate mofetil: results of a pilot study","volume":"22","author":"Ballarin","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2012.03.008_bib35","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1111\/j.1432-2277.1998.tb01197.x","article-title":"Low-dose tacrolimus (FK506)-based immunosuppressive protocol in living donor renal transplantation","volume":"11","author":"Kokado","year":"1998","journal-title":"Transpl Int"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812001580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812001580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T20:05:28Z","timestamp":1593979528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291812001580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0149291812001580"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2012.03.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}